Tuesday, March 13, 2018

Illumina Sets Chief Medical Officer

San Diego-based life sciences equipment maker Illumina said this morning that it has appointed Dr. Phil Febbo as its Chief Medical Officer (CMO). Febbo was most recently CMO of Genomic Health, and also had served as Professor of Medicine and Urology at the University of California, San Francisco (UCSF). Acording to Illumina, Febbo has worked in the area for the past 25 years. According to the company, Febbo will be responsible for developing and executing on the Company's medical strategy to drive genomic testing into healthcare practice.

---